Spain’s antitrust watchdog has opened an investigation into six large drug makers over long-standing accusations from wholesalers that the companies engage in unfair pricing schemes.
The National Competition and Markets Commission, or CNMC, is actually reviving a 10-year-old case at the direction of Spain’s Supreme Court, which last August ruled that an earlier decision not to pursue an investigation was incorrect. The companies that are under investigation are Pfizer, Merck, Novartis, Sanofi, Eli Lilly, and the Janssen-Cilag unit of Johnson & Johnson.
About the Author Reprints
